Stock profile

Amrutanjan Health Care Limited(AMRUTANJAN.NS)

Country: IndiaSector: HealthcareIndustry: Drug Manufacturers - Specialty & GenericExchange: NSE
P/E TTM
24.5
History
P/E NTM
66.6
Market cap
15.29B
Currency INR
KvantraRanki38
Value30
Quality72
Momentum3
Current price
491.60+0.67%
Benchmarks

No price history available.

Key financial summary

Financials in INR
2020202120222023202420252026TTM2027E
Total revenueINRm2,6073,3154,0543,7954,2124,5055,026N/AN/A
Operating profitINRmLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net profitINRm251612672398450508579N/AN/A
EPS reportedINRLockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating cashflow per shareINRLockedLockedLockedLockedLockedLockedLockedLockedLocked
Capex per shareINRLockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF per shareINRLockedLockedLockedLockedLockedLockedLockedLockedLocked
Free cash flowINRmLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debtINRmLockedLockedLockedLockedLockedLockedLockedLockedLocked
Book value equityINRmLockedLockedLockedLockedLockedLockedLockedLockedLocked
Book value per shareINRLockedLockedLockedLockedLockedLockedLockedLockedLocked
Number of sharesmLockedLockedLockedLockedLockedLockedLockedLockedLocked
DPS (TTM paid)INRLockedLockedLockedLockedLockedLockedLockedLockedLocked

Financial summary

Financials in INR
2020202120222023202420252026TTM2027E
Value
P/E LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/B LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/S LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
P/FCF LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EV/EBITDA LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EV/Sales LTMxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Earnings Yield LTM%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF Yield%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Quality
ROE%LockedLockedLockedLockedLockedLockedLockedLockedLocked
ROIC%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating margin%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Gross margin%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF/Sales%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Growth and momentum
EPS Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Sales Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Net Income Growth YoY%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Operating Profit Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Dividend and capital structure
Dividend Yield%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Dividend Growth%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Payout Ratio%LockedLockedLockedLockedLockedLockedLockedLockedLocked
FCF/DebtxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net Debt/EBITDAxLockedLockedLockedLockedLockedLockedLockedLockedLocked
EBIT/Net interestxLockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/market cap%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Net debt/Equity%LockedLockedLockedLockedLockedLockedLockedLockedLocked
Gross debt/equity%LockedLockedLockedLockedLockedLockedLockedLockedLocked

Ratings

Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked
Number of covering analystsLocked

Based on consensus from external analysts. Not Kvantra's opinion.

Company overview

Established in Chennai, India, in 1893, Amrutanjan Health Care Limited, formerly known as Amrutanjan Limited until its renaming in 2007, is a prominent manufacturer, supplier, and vendor of a broad array of wellness products. The company primarily operates across its OTC Products, Beverages, and Others divisions. Its core offerings include ayurvedic pain relief balms, non-alcoholic drinks, and feminine hygiene products. For pain management, Amrutanjan provides a comprehensive range of solutions such as traditional pain balms, various roll-ons, back pain lotions, body pain gels, joint muscle sprays, and diclofenac-based remedies. To address congestion, the company offers cold rubs, cough syrups, nasal inhalers, and Swas Mints. Additionally, its product line features sanitary napkins for women, corn caps, and hand sanitizers. Within its beverage segment, it manufactures juice drinks marketed under the Fruitnik and Fruitnik Electro+ brand names. Amrutanjan also extends its services by operating a pain management center. The company's global presence is marked by product exports to the Middle East, Africa, Southeast Asia, and other international markets.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryIndia
Trades inINR

Similar companies

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Amrutanjan Health Care Limited (AMRUTANJAN.NS)

AMRUTANJAN.NS · NSE · Healthcare
491.60+0.67%
Sign up to track this stock

No price history available.

KvantraRank38
P/E TTM24.5
P/E NTM66.6
Market cap15.29B
KvantraRank?38 / 100
Value
30
Quality
72
Momentum
3
Financialsin INR
20242025TTM2026
Ratings
Strong Buy
Locked
Buy
Locked
Hold
Locked
Sell
Locked
Strong Sell
Locked

Based on consensus from external analysts. Not Kvantra's opinion.

About

Established in Chennai, India, in 1893, Amrutanjan Health Care Limited, formerly known as Amrutanjan Limited until its renaming in 2007, is a prominent manufacturer, supplier, and vendor of a broad array of wellness products. The company primarily operates across its OTC Products, Beverages, and Others divisions. Its core offerings include ayurvedic pain relief balms, non-alcoholic drinks, and feminine hygiene products. For pain management, Amrutanjan provides a comprehensive range of solutions such as traditional pain balms, various roll-ons, back pain lotions, body pain gels, joint muscle sprays, and diclofenac-based remedies. To address congestion, the company offers cold rubs, cough syrups, nasal inhalers, and Swas Mints. Additionally, its product line features sanitary napkins for women, corn caps, and hand sanitizers. Within its beverage segment, it manufactures juice drinks marketed under the Fruitnik and Fruitnik Electro+ brand names. Amrutanjan also extends its services by operating a pain management center. The company's global presence is marked by product exports to the Middle East, Africa, Southeast Asia, and other international markets.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryIndia
Trades inINR

For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.

Unlock all fundamental data for this stock

Unlimited access to every company

See plans

Unlock all fundamental data for this stock

Unlimited access to every company

See plans